Skip to main content
SpringerLink
Log in

Antibacterials/pembrolizumab/prednisolone

Immune-mediated colitis and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Preda CM, et al. Pembrolizumab induced steroid resistant immune mediated colitis and concurrent Clostridioides difficile infection. Journal of Gastrointestinal and Liver Diseases 30: 411-413, No. 3, Sep 2021. Available from: URL: http://doi.org/10.15403/jgld-3923

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antibacterials/pembrolizumab/prednisolone. Reactions Weekly 1888, 42 (2022). https://doi.org/10.1007/s40278-022-08384-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-08384-5

Search

Navigation